Detalles de la búsqueda
1.
Acute kidney injury as a risk factor for mortality in oncological patients receiving checkpoint inhibitors.
Nephrol Dial Transplant
; 37(5): 887-894, 2022 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-33547795
2.
Drug Cost Avoidance Resulting from Participation in Clinical Trials: A 10-Year Retrospective Analysis of Cancer Patients with Solid Tumors.
Cancers (Basel)
; 16(8)2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38672610
3.
Use of Drugs in Clinical Practice and the Associated Cost of Cancer Treatment in Adult Patients with Solid Tumors: A 10-Year Retrospective Cohort Study.
Curr Oncol
; 30(9): 7984-8004, 2023 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-37754495
4.
Selection process and causes of non-eligibility for CD19 CAR-T cell therapy in patients with relapsed/refractory aggressive B-cell non-Hodgkin lymphoma in a European center.
Leuk Lymphoma
; 62(9): 2288-2291, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33899648
5.
A pharmacodynamic/pharmacokinetic study of ficlatuzumab in patients with advanced solid tumors and liver metastases.
Clin Cancer Res
; 20(10): 2793-804, 2014 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24634378
6.
Aprataxin tumor levels predict response of colorectal cancer patients to irinotecan-based treatment.
Clin Cancer Res
; 16(8): 2375-82, 2010 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20371676
Resultados
1 -
6
de 6
1
Próxima >
>>